Latin American Rapid Test Markets for Infectious Diseases

Research Overview

This Frost & Sullivan research service entitled Latin American Rapid Tests Market for Infectious Diseases provides an overview on the Latin American region in terms of its stage of development in this market. It focuses on key market drivers and restraints shaping the current market and depicting the future trends together with a comprehensive quantitative analysis covering current market size, market share, and a 5 year market forecast for the three countries covered in the study: Brazil, Mexico and Argentina. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: Rapid tests application in the detection of HIV, Hepatitis C Virus, and Chagas for the three countries covered by this study.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this analysis:

• Rapid Tests for HIV detection
• Rapid Tests for HCV detection
• Rapid Tests for Chagas detection

Technologies

The following technologies are covered in this research:

• Inmunochromatography, DIA, HAI
• HAI, Immunoassays
• HAI

Market Overview

Rapid Test markets are undergoing dynamic development in many countries around the world. New techniques matching needs on sensibility and specificity of these tests are being marketed worldwide. Latin America is unfolding as a region of major untapped opportunities within this category. Both cultural and technological drivers are triggering new interest in Latin American healthcare distribution for simple diagnostics for fatal illness categories.

Latin America offers a diverse landscape in terms of market development for Rapid Tests for infectious diseases. While Mexico is relatively highly developed with respect to product distribution and technology for rapid test, Brazil and Argentina are in an earlier stage of product and market expansion and are likely to experience a significant inflow of new products and competitors in the next five years.